Tradestie Institutional Equity Comparison Engine

IHF vs IAK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IHF Overall Edge

IHF Captures Institutional Edge (1โ€“0 Pillars ยท 3โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to iShares U.S. Healthcare Providers ETF (IHF) driven by superior Momentum & Technical. Fundamentally, IHF trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus IAK at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, IHF sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against IAK sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
IHF N/M vs IAK N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner IHF
1Y +26.0% vs +14.7% ยท 52W Pos 96% vs 90%
Options & Structure Winner Tie
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (<1st %ile IV)
IHF NYSE Arca
iShares U.S. Healthcare Providers ETF
Institutional Equity
$60.79
+0.63% 1D
Market Cap N/A
1M Return +3.65%
1Y Return +25.96%
Forward P/E N/M
Unified AI Score
47.8 / 100 HOLD
Tech 36.0 Fund 47.0 Flow 50.0 Mom 50.0
IAK NYSE Arca
iShares U.S. Insurance ETF
Institutional Equity
$153.39
+0.14% 1D
Market Cap N/A
1M Return +5.29%
1Y Return +14.74%
Forward P/E N/M
Unified AI Score
39.9 / 100 SELL
Tech 29.0 Fund 42.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IHF +25.96% IAK +14.74% Spread: +11.22 pp (IHF Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IHF TTM Op. Margin: N/A IAK TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IHF vs IAK. Trailing 12-month operating profitability (IHF N/A vs IAK N/A) and valuation multiples (IHF N/M vs IAK N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IHF (3) vs IAK (0)
Institutional Metric IHF IAK Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 96% ($41โ€“$62) 90% ($125โ€“$157) Stronger Trend IHF
Beta / 30D Volatility Risk Regime 0.30ฮฒ ยท 18% Vol -0.07ฮฒ ยท 20% Vol Lower Realized Risk IHF
Unified Institutional Score Composite Signal 47.8 / 100 (HOLD) 39.9 / 100 (SELL) Higher Composite IHF

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IHF vs IAK Buy Guide
IHF UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live IHF Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IAK UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live IAK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IHF nor IAK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.